CAD 0.72
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | -2.92 Million | -4.59 Million | -3.34 Million | -5.08 Million | -3.93 Million | -4.23 Million |
Net Income | -8.92 Million | -8.75 Million | -6.8 Million | -9 Million | -5.39 Million | -5.18 Million |
Depreciation & Amortization | 98 Thousand | 80.63 Thousand | 111.67 Thousand | 178.49 Thousand | 189.91 Thousand | 100.33 Thousand |
Deferred income taxes | -6.66 Million | - | -187.76 Thousand | 50.62 Thousand | 927.12 Thousand | -762.1 Thousand |
Stock-based compensation | 6.37 Million | 4.94 Million | 2.88 Million | 1.75 Million | 17.22 Thousand | 297.26 Thousand |
Change in working capital | 140 Thousand | -7040.00 | 80.75 Thousand | 47.33 Thousand | 112.72 Thousand | 225.36 Thousand |
Other non-cash items | 6.05 Million | -856.78 Thousand | 565.42 Thousand | 1.88 Million | 216 Thousand | 1.09 Million |
Investing Cash Flow | -13.35 Million | -13.06 Million | -19.78 Million | -2.83 Million | -2.12 Million | -15.56 Million |
Investments in PPE | -17.52 Million | -14.03 Million | -20.09 Million | -2.84 Million | -12.12 Million | -15.16 Million |
Acquisitions | - | - | - | 2000.00 | - | -400 Thousand |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | 4.17 Million | 56.11 Thousand | - | - | 10 Million | - |
Other Investing Activities | 6863.00 | 916.3 Thousand | 319.43 Thousand | 98.34 | 10 Thousand | -400.00 |
Financing Cash Flow | 48.93 Million | 5.41 Million | 46.78 Million | 33.08 Million | -94.84 Thousand | - |
Debt repayment | -67 Thousand | -8.82 Million | -87.31 Thousand | -4.03 Million | -94.84 Thousand | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | 49 Million | 7.99 Million | 34.5 Million | 24.07 Million | - | - |
Other Financing Activities | -2.32 Million | 6.23 Million | 12.36 Million | 13.04 Million | -94.85 | - |
Accounts receivables | -92 Thousand | 53.36 Thousand | -117.63 Thousand | 13.36 Thousand | 170.13 Thousand | -86.06 Thousand |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | 232 Thousand | -60.4 Thousand | 198.38 Thousand | 33.97 Thousand | -57.4 Thousand | -50.01 Thousand |
Cash at beginning of period | 41.19 Million | 53.6 Million | 29.94 Million | 4.78 Million | 10.94 Million | 30.73 Million |
Cash at end of period | 73.85 Million | 41.35 Million | 53.6 Million | 29.94 Million | 4.78 Million | 10.94 Million |
Capital Expenditure | -17.52 Million | -14.03 Million | -20.09 Million | -2.84 Million | -12.12 Million | -15.16 Million |
Effect of forex changes on cash | -23.00 | - | - | - | - | - |
Net cash flow / Change in cash | 32.65 Million | -12.24 Million | 23.65 Million | 25.16 Million | -6.15 Million | -19.79 Million |
Free Cash Flow | -20.44 Million | -18.63 Million | -23.44 Million | -7.92 Million | -16.06 Million | -19.39 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -3.44 Million | -1.45 Million | -8.92 Million | -2.79 Million | -416 Thousand | -2.36 Million |
Depreciation & Amortization | 34 Thousand | 32 Thousand | 98 Thousand | 32 Thousand | 26 Thousand | 20 Thousand |
Deferred income taxes | - | - | -6.66 Million | -920 Thousand | -1.18 Million | 270 Thousand |
Stock-based compensation | 1.54 Million | 3.78 Million | 6.37 Million | 780 Thousand | 1.03 Million | 1.42 Million |
Change in working capital | 1.14 Million | -1.08 Million | 140 Thousand | 542 Thousand | 173 Thousand | 93 Thousand |
Other non-cash items | 2.62 Million | 1.54 Million | 6.05 Million | 1.68 Million | -649 Thousand | -501 Thousand |
Investing Cash Flow | -10.33 Million | -97.56 Million | -13.35 Million | -243 Thousand | -3.57 Million | -4.26 Million |
Investments in PPE | -10.33 Million | -7.56 Million | -17.52 Million | -4.41 Million | -4.22 Million | -4.84 Million |
Acquisitions | - | - | - | - | - | - |
Investment purchases | -10 Million | -90 Million | - | - | - | - |
Sales/Maturities of investments | 10 Million | - | 4.17 Million | 4.17 Million | - | - |
Other Investing Activities | 1173.00 | -88.65 Thousand | 6863.00 | 5093.00 | 649 Thousand | 584 Thousand |
Financing Cash Flow | 17.6 Million | 74.47 Million | 48.93 Million | 24.78 Million | 7.57 Million | 6.87 Million |
Debt repayment | -22 Thousand | -21 Thousand | -67 Thousand | -22 Thousand | -18 Thousand | -14 Thousand |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | 17.62 Million | 74.49 Million | 49 Million | 24.81 Million | 7.83 Million | 6.75 Million |
Other Financing Activities | -42 Thousand | -4.24 Million | -2.32 Million | -1.48 Million | -242 Thousand | 131 Thousand |
Accounts receivables | -1.01 Million | -401 Thousand | -92 Thousand | -76 Thousand | 61 Thousand | 63 Thousand |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | 2.15 Million | -682 Thousand | 232 Thousand | 618 Thousand | 112 Thousand | 30 Thousand |
Cash at beginning of period | 49.33 Million | 73.85 Million | 41.19 Million | 49.98 Million | 47.17 Million | 45.62 Million |
Cash at end of period | 55.88 Million | 49.33 Million | 73.85 Million | 73.85 Million | 50.14 Million | 47.17 Million |
Capital Expenditure | -10.33 Million | -7.56 Million | -17.52 Million | -4.41 Million | -4.22 Million | -4.84 Million |
Effect of forex changes on cash | - | - | -23.00 | - | - | - |
Net cash flow / Change in cash | 6.55 Million | -24.52 Million | 32.65 Million | 23.86 Million | 2.97 Million | 1.55 Million |
Free Cash Flow | -11.04 Million | -8.99 Million | -20.44 Million | -5.09 Million | -5.24 Million | -5.9 Million |
CLHLF
WOCKPHARMA
ASBFY
5247
IKIO
HUHTAMAKI